PEAK6 Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

PEAK6 Group’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,500	Closed	-$88K	–	5079
2017 Q4	$88K	Buy	+1,500	New	+$94.6K	﹤0.01%	3588
2017 Q3	–	Sell	-900	Closed	-$109K	–	5184
2017 Q2	$109K	Buy	+900	New	+$104K	﹤0.01%	3805
2017 Q1	–	Sell	-2,700	Closed	-$293K	–	5166
2016 Q4	$293K	Buy	2,700 +1,900	+238%	+$226K	﹤0.01%	2996
2016 Q3	$132K	Sell	800 -11,500	-93%	-$1.81M	﹤0.01%	3424
2016 Q2	$1.75M	Buy	+12,300	New	+$1.79M	0.01%	1335
2015 Q4	–	Sell	-6,400	Closed	-$1.06M	–	5412
2015 Q3	$1.06M	Sell	6,400 -1,600	-20%	-$352K	0.01%	2135
2015 Q2	$1.93M	Buy	8,000 +5,600	+233%	+$1.49M	0.01%	1503
2015 Q1	$677K	Buy	+2,400	New	+$520K	0.01%	2268
2014 Q4	–	Sell	-2,500	Closed	-$592K	–	5251
2014 Q3	$592K	Buy	+2,500	New	+$637K	﹤0.01%	2326
2014 Q2	–	Sell	-100	Closed	-$33K	–	5266
2014 Q1	$33K	Buy	+100	New	+$33.7K	﹤0.01%	4443

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

PEAK6 Group's ICPT Position: Q2 2018 in Review

PEAK6 Group reduced its Intercept Pharmaceuticals, Inc. (ICPT) stake by 57% in Q2 2018, selling an estimated $61.4K and leaving 624 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #3916.

PEAK6 Group first reported a position in ICPT in Q1 2014 and has held it in 13 quarters since. The position peaked at $1.1M in Q3 2017. 163 funds tracked by Wall St. Rank hold ICPT as of Q2 2018.

PEAK6 Group held 624 shares of Intercept Pharmaceuticals, Inc. worth $52K as of Q2 2018.
PEAK6 Group sold 838 Intercept Pharmaceuticals, Inc. shares in Q2 2018, an estimated $61.4K.
Intercept Pharmaceuticals, Inc. made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3916 holding.
PEAK6 Group first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and has held it in 13 quarters since.
PEAK6 Group's Intercept Pharmaceuticals, Inc. position peaked at $1.1M in Q3 2017.
163 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.